High tPA-expression in primary melanoma of the limb correlates with good prognosis
Cilia M. Ferrier(Radboud University Nijmegen), D. J. Ruiter(Radboud University Nijmegen), Ferdy J. Lejeune, Alexander M.M. Eggermont(University Medical Center Utrecht), Ulrich R. Kleeberg(European Organisation for Research and Treatment of Cancer), Stefan Suciu(St James's University Hospital), B.B.R. Kroon, H. Schraffordt Koops, Huub Straatman(Pharmo Institute), Goos N.P. van Muijen(Radboud University Medical Center), Winny L. van Geloof(Radboud University Nijmegen)
Cited by 44
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k